all news

Wed, 11 Jun 2025 Business Wire

Capstan Therapeutics Announces Initiation of Phase 1 Trial of Lead In Vivo CAR-T Therapy, CPTX2309, for Treating Autoimmune Disease

Mon, 9 Jun 2025 Yahoo! Finance

Sun Life partners with Wellthy to provide life insurance members with concierge care for end-of-life planning, loss and grief

Thu, 5 Jun 2025 Business Wire

TRexBio Doses First Participant in Phase 1 Trial of TRB-061, a Novel TNFR2 Agonist for Atopic Dermatitis and Other Inflammatory Diseases

Tue, 3 Jun 2025 Associated Press

Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression

Tue, 3 Jun 2025 Business Wire

Leyden Labs Lands €20 Million EIB Investment Facilitated by HERA to Advance Pandemic Preparedness Activities

Mon, 2 Jun 2025 PR Newswire

Freenome Announces JAMA Publication of Data from Pivotal Study of its Blood-Based Test for Colorectal Cancer

Thu, 29 May 2025 GlobeNewswire

Auron Announces First Patient Dosed in Phase 1 Clinical Trial of AUTX-703 in Advanced Hematologic Malignancies

Thu, 22 May 2025 Business Wire

Volastra Announces Initial Data from First-in-Human Phase I/II Trial of Novel KIF18A Inhibitor VLS-1488 to be Presented at 2025 ASCO Annual Meeting

Wed, 21 May 2025 Associated Press

Triveni Bio Doses First Healthy Volunteers in Clinical Trial for TRIV-509, Coinciding with Preclinical Data Presentations Further Validating Novel Kallikrein 5/7 Biology in Atopic Dermatitis

Sun, 18 May 2025 Silicon Valley Daily

Ernst & Young Names Bay Area Finalists for Entrepreneur of the Year – Silicon Valley Daily

Fri, 16 May 2025 GlobeNewswire

CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

Thu, 15 May 2025 Business Wire

Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X Syndrome

Thu, 15 May 2025 Business Wire

QurAlis Announces Exclusive License on Novel Mechanism for Fragile X Syndrome (FXS) to Enable Development of First Potential Disease-Modifying Therapy

Wed, 14 May 2025 Business Wire

Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Wed, 14 May 2025 PR Newswire

Cohere Health Secures $90M Series C to Expand AI-Powered Platform Transforming Health Plan Clinical Decision-Making

Tue, 13 May 2025 Associated Press

ByHeart Launches Anywhere Pack: A First-of-Its-Kind Travel-Ready Infant Formula for Modern Parents

Thu, 8 May 2025 Business Wire

OM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025

Thu, 8 May 2025 GlobeNewswire

PwC and FloQast and PwC Belgium Announce Strategic Partnership to Transform Financial Close

Wed, 30 Apr 2025 Dyno Therapeutics

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American S

Wed, 30 Apr 2025 PR Newswire

ELLIS ISLAND HONORS SOCIETY ANNOUNCES THE 2025 ELLIS ISLAND MEDALS OF HONOR RECIPIENTS

Wed, 30 Apr 2025 BioSpace

Engine Biosciences Appoints Renowned Drug Discovery and Development Leader Robert Abraham, PhD, as Chief Scientific Officer

Mon, 28 Apr 2025 Access Newswire

Sonrai Security Unveils AI-Powered Just-in-Time Access for AWS

Mon, 28 Apr 2025 Yahoo! Finance

Ankyra Therapeutics Announces Phase 1 Clinical Data at the 2025 AACR Annual Meeting and the first patient has been dosed with tolododekin alfa and cemiplimab

Mon, 28 Apr 2025 Yahoo! Finance

Auron Presents Preclinical Data Highlighting the Activity of AUTX-703 in Prostate Cancer at 2025 AACR Annual Meeting

Mon, 28 Apr 2025 Associated Press

Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth

Wed, 23 Apr 2025 The Healthcare Technology Report

The Top 25 Healthcare AI Companies of 2025

Tue, 22 Apr 2025 HTC- HRTECHCUBE

AI Boosts Qstream’s Growth and Customer Value Potential

Tue, 22 Apr 2025 Business Wire

OM1 Adds 1 Million Patients to Its Mental Health Network, Significantly Expanding Specialty Coverage and Driving New Possibilities for Real-World Research and Personalized Care

Wed, 16 Apr 2025 Associated Press

Propy Partners with Proof to Streamline Notary Services, Making Home Buying Faster and Safer

Thu, 10 Apr 2025 Business Wire

Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S-4321, a Novel Bifunctional Antibody that Agonizes PD-1 and FcγRIIb Inhibitory Receptors for the Treatment of Autoimmune Disease